Prospective study of the association between the proline to alanine codon 12 polymorphism in the PPARgamma gene and type 2 diabetes - PubMed (original) (raw)

Prospective study of the association between the proline to alanine codon 12 polymorphism in the PPARgamma gene and type 2 diabetes

Asli Memisoglu et al. Diabetes Care. 2003 Oct.

Abstract

Objective: To determine whether the Pro12Ala polymorphism in the PPARgamma gene was associated with risk of type 2 diabetes in the Nurses' Health Study.

Research design and methods: The study was a nested case-control study of 387 incident cases of type 2 diabetes and 771 matching control subjects nested within the Nurses' Health Study, a prospective cohort study. Association between PPARgamma genotype and incident type 2 diabetes was estimated using logistic regression.

Results: Carriers of the PPARgamma variant 12Ala allele had reduced risk of type 2 diabetes compared with noncarriers. Unadjusted and adjusted odds ratios of type 2 diabetes were 0.74 (95% CI 0.55-1.00) and 0.72 (0.52-0.99), respectively.

Conclusions: The results of this study provide further support for an inverse association between the PPARgamma variant 12Ala allele and risk of type 2 diabetes.

PubMed Disclaimer

Similar articles

• Is a Pro12Ala polymorphism of the PPARgamma2 gene related to obesity and type 2 diabetes mellitus in the Czech population?
  Srámková D, Kunesová M, Hainer V, Hill M, Vcelák J, Bendlová B. Srámková D, et al. Ann N Y Acad Sci. 2002 Jun;967:265-73. doi: 10.1111/j.1749-6632.2002.tb04282.x. Ann N Y Acad Sci. 2002. PMID: 12079854
• The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.
  Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES. Altshuler D, et al. Nat Genet. 2000 Sep;26(1):76-80. doi: 10.1038/79216. Nat Genet. 2000. PMID: 10973253
• Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus.
  Ringel J, Engeli S, Distler A, Sharma AM. Ringel J, et al. Biochem Biophys Res Commun. 1999 Jan 19;254(2):450-3. doi: 10.1006/bbrc.1998.9962. Biochem Biophys Res Commun. 1999. PMID: 9918859
• [The role of PPARgamma in the onset of type 2 diabetes].
  Hara K, Yamauchi T, Kubota N, Tobe K, Yamazaki T, Nagai R, Kadowaki T. Hara K, et al. Nihon Yakurigaku Zasshi. 2003 Oct;122(4):317-24. doi: 10.1254/fpj.122.317. Nihon Yakurigaku Zasshi. 2003. PMID: 14501167 Review. Japanese.
• The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism.
  Stumvoll M, Häring H. Stumvoll M, et al. Diabetes. 2002 Aug;51(8):2341-7. doi: 10.2337/diabetes.51.8.2341. Diabetes. 2002. PMID: 12145143 Review.

Cited by

• PPAR gamma and human metabolic disease.
  Semple RK, Chatterjee VK, O'Rahilly S. Semple RK, et al. J Clin Invest. 2006 Mar;116(3):581-9. doi: 10.1172/JCI28003. J Clin Invest. 2006. PMID: 16511590 Free PMC article. Review.
• Relationships of dietary patterns with body composition in older adults differ by gender and PPAR-γ Pro12Ala genotype.
  Anderson AL, Harris TB, Houston DK, Tylavsky FA, Lee JS, Sellmeyer DE, Sahyoun NR. Anderson AL, et al. Eur J Nutr. 2010 Oct;49(7):385-94. doi: 10.1007/s00394-010-0096-9. Epub 2010 Feb 21. Eur J Nutr. 2010. PMID: 20174813 Free PMC article.
• Interaction between the NOS3 gene and obesity as a determinant of risk of type 2 diabetes: the Atherosclerosis Risk in Communities study.
  Bressler J, Pankow JS, Coresh J, Boerwinkle E. Bressler J, et al. PLoS One. 2013 Nov 20;8(11):e79466. doi: 10.1371/journal.pone.0079466. eCollection 2013. PLoS One. 2013. PMID: 24278136 Free PMC article.
• Is the rs1801282 (G/C) Polymorphism of PPAR - Gamma Gene Associated with T2DM in Iraqi People?
  Al-Naemi AH, Ahmad AJ. Al-Naemi AH, et al. Open Access Maced J Med Sci. 2018 Mar 14;6(3):447-455. doi: 10.3889/oamjms.2018.156. eCollection 2018 Mar 15. Open Access Maced J Med Sci. 2018. PMID: 29610599 Free PMC article.
• Genetic prediction of future type 2 diabetes.
  Lyssenko V, Almgren P, Anevski D, Orho-Melander M, Sjögren M, Saloranta C, Tuomi T, Groop L; Botnia Study Group. Lyssenko V, et al. PLoS Med. 2005 Nov 1;2(12):e345. doi: 10.1371/journal.pmed.0020345. PLoS Med. 2005. PMID: 17570749 Free PMC article. Clinical Trial.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Medical

  • MedlinePlus Health Information